Artificial and bioartificial liver support.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Seminars in liver disease (Print)

• Publication date

  2008-05-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1055/s-2008-1073120PMID 18452120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.

  2008cited by this paper
• Cells for bioartificial liver devices: The human hepatoma‐derived cell line C3A produces urea but does not detoxify ammonia

  2008cited by this paper
• Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice

  2007cited by this paper
• Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.

  2007cited by this paper
• Epidemiology of acute liver failure

  2007cited by this paper
• Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.

  2006cited by this paper
• Generation of hybrid hepatocytes by cell fusion from monkey embryoid body cells in the injured mouse liver

  2006cited by this paper
• Prometheus system: a technological support in liver failure.

  2006cited by this paper
• Rapid, large‐scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver

  2005cited by this paper
• Molecular adsorbent recirculating system for acute and acute‐on‐chronic liver failure: A meta‐analysis

  2004cited by this paper
• Near completely humanized liver in mice shows human-type metabolic responses to drugs.

  2004cited by this paper
• Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure

  2004cited by this paper
• Binding of bilirubin and bromosulphthalein to albumin: Implications for understanding the pathophysiology of liver failure and its management

  2004cited by this paper
• Hepatic tissue engineering.

  2004cited by this paper
• Prometheus--a new extracorporeal system for the treatment of liver failure.

  2003cited by this paper
• Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells

  2003cited by this paper
• Membrane pore size impacts performance of a xenogeneic bioartificial liver1

  2003cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002cited by this paper
• Phase I clinical trial with the AMC-bioartificial liver.

  2002influential reference
• Advances in bioartificial liver devices

  2001cited by this paper
• Results of a phase I trial evaluating a liver support device utilizing albumin dialysis.

  2001cited by this paper
• Safety Observations in Phase I Clinical Evaluation of the Excorp Medical Bioartificial Liver Support System after the First Four Patients

  2001cited by this paper
• Novel strategies for immortalization of human hepatocytes.

  2001cited by this paper
• Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.

  1999cited by this paper
• Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group.

  1999cited by this paper
• Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.

  1999cited by this paper
• Temporary Extracorporeal Liver Support for Severe Acute Alcoholic Hepatitis Using the Biologic-Dt

  1998cited by this paper
• Ex Vivo Hepatic Gene Therapy of a Mouse Model of Hereditary Tyrosinemia Type I

  1998cited by this paper
• No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys.

  1998cited by this paper
• Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

  1997cited by this paper
• Extracorporeal liver support: cell-based therapy for the failing liver.

  1997influential reference
• Infection of human cells by an endogenous retrovirus of pigs

  1997cited by this paper
• Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure

  1996cited by this paper
• Acute Liver Failure: Clinical experience with an extracorporeal liver assist device

  1996cited by this paper
• Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I

  1995cited by this paper
• Hepatocarcinogenesis in transgenic mice.

  1995cited by this paper
• Complete reconstitution of mouse liver with xenogeneic hepatocytes.

  1995cited by this paper
• THE USE OF ABO‐INCOMPATIBLE GRAFTS IN LIVER TRANSPLANTATION: A LIFE‐SAVING PROCEDURE IN HIGHLY SELECTED PATIENTS

  1995cited by this paper
• Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.

  1994cited by this paper
• The Hepatix extracorporeal liver assist device: initial clinical experience.

  1994cited by this paper
• Assessment of Artificial Liver Support Technology

  1992cited by this paper
• Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene.

  1991cited by this paper
• Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency.

  1989cited by this paper
• A hybrid bioartificial liver composed of multiplated hepatocyte monolayers.

  1988cited by this paper
• Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures

  1987cited by this paper
• Hybrid bioartificial liver in hepatic failure: preliminary clinical report.

  1987cited by this paper

• Bioartificial liver: Where lies the path ahead—A review

  2025cites this paper
• Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development

  2024cites this paper
• Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment

  2023cites this paper
• Cryopreservation of Whole Rat Livers by Vitrification and Nanowarming

  2022cites this paper
• Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions

  2022cites this paper
• Bioartificial livers: a review of their design and manufacture

  2022cites this paper
• Regenerative Medicine Biomaterials

  2021cites this paper
• Differentiation of Stem Cells into Hepatocyte Lineage: In Vitro Cell Culture, In Vivo Transplantation in Animal Models

  2021cites this paper
• Liver Assist Systems in Pediatric Liver Failure

  2021cites this paper
• Liver Assist Devices for Liver Failure

  2020cites this paper
• Artificial liver support systems

  2020cites this paper
• Efficient Generation of an Fah/Rag2 Dual-Gene Knockout Porcine Cell Line Using CRISPR/Cas9 and Adenovirus

  2019cites this paper
• Intraperitoneal transplantation of bioengineered humanized liver grafts supports failing liver in acute condition.

  2019cites this paper
• Cell Culture Bioprocess Technology: Biologics and Beyond

  2018cites this paper
• Utilizing recycled prepreg carbon fiber and date pit powder for detoxification

  2018cites this paper
• Emerging Role of Extracorporeal Support in Acute and Acute-on-Chronic Liver Failure: Recent Developments

  2018cites this paper
• Extracorporeal Liver Support Systems in Paediatric Liver Failure

  2017cites this paper
• Treatment of Hepatic Malignances and Disorders: The Role of Liver Bioengineering

  2017cites this paper
• Effects of therapeutic plasma exchange on early allograft dysfunction after liver transplantation

  2017cites this paper
• Platelets in liver regeneration

  2017cites this paper
• Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support

  2017cites this paper
• Hemadsorption with Adult CytoSorb® in a Low Weight Pediatric Case

  2017cites this paper
• Experimental and mathematical modelling of the culture and cryopreservation of a bioartificial liver device utilizing a 3D cell scaffold construction

  2016cites this paper
• Hepatocyte culture in a radial-flow bioreactor with plasma polypyrrole coated scaffolds

  2016cites this paper
• New Phase of Growth for Xenogeneic-Based Bioartificial Organs

  2016cites this paper
• Organic-polymeric radial flow biorreactor for liver models

  2016cites this paper
• Extracorporeal Liver Support Systems in Paediatric Liver Failure

  2016cites this paper
• Stem Cell Therapies for Treatment of Liver Disease

  2016cites this paper
• Hybrid Scaffolds on Radial Flow Bioreactor to Generate Liver Tissue Models

  2015cites this paper
• Endotoxinämie im Akuten Leberversagen am Grosstiermodell

  2015influential citation
• Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure.

  2015cites this paper
• Prognosis of acute-on-chronic liver failure patients treated with artificial liver

  2015cites this paper
• Translational Regenerative Medicine—Hepatic Systems

  2015cites this paper
• Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options

  2015cites this paper
• Development of implantable cell-tissue-engineering designs of auxiliary liver for the treatment of liver failure

  2015cites this paper
• Safety of Human Hepatoma Cell-Line Constructing Bioartificial Liver Supporting System Treating Patients with Liver Failure.

  2014cites this paper
• In- vitro- evaluation der Open Loop Albumin Dialysis (OLAD)

  2014cites this paper
• Neurologic manifestations of acute liver failure.

  2014cites this paper
• Bioreactor technologies to support liver function in vitro.

  2014cites this paper
• Construction of bone marrow mesenchymal cells-derived engineered hepatic tissue and its therapeutic effect in rats with 90% subtotal hepatectomy.

  2014cites this paper
• Cellular therapy for liver disease.

  2014cites this paper
• Ischaemic hepatitis / shock liver Post cardiac surgery Liver trauma Neoplastic Leukaemia Lymphoma Hepatocellular carcinoma Other Reye ’ s syndrome Hypothermia Heat stroke Massive liver resection Sickle cell anaemia

  2014cites this paper
• Cold Storage of Rat Hepatocyte Spheroids

  2014cites this paper
• Galactose-functionalized gelatin hydrogels improve the functionality of encapsulated HepG2 cells.

  2014cites this paper
• Acute liver failure and transplantation in children.

  2014cites this paper
• A novel technique for central hepatectomy: Maintain the blood supply and biliary drainage on one side and the blood supply from the portal vein on the other

  2013cites this paper
• The newly established human liver cell line: a potential cell source for the bioartificial liver in the future

  2013cites this paper
• Successful treatment of drug‐induced acute liver failure with high‐volume plasma exchange

  2013cites this paper
• Transdiferenciación de fibroblastos a hepatocitos mediante reprogramación celular: papel de Gata4 en el bloqueo de la reprogramación de células somáticas

  2013cites this paper
• Metabolically Functional Hepatocyte-Like Cells from Human Umbilical Cord Lining Epithelial Cells

  2013cites this paper
• Introduction to the Revised American Association for the Study of Liver Diseases Position Paper on Acute Liver Failure 2011

  2012influential citation
• Cell therapies for liver diseases

  2012cites this paper
• Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study

  2012cites this paper
• Key challenges to the development of extracorporeal bioartificial liver support systems.

  2012cites this paper
• Gene Transfer of c-met Confers Protection Against d-Galactosamine/Lipopolysaccharide-Induced Acute Liver Failure

  2012cites this paper
• Feasibility of orthotopic fetal liver transplantation: an experimental study.

  2012cites this paper
• Advances in stem cell therapy.

  2012cites this paper
• Liver support devices

  2012cites this paper
• Antithrombin III injection via the portal vein suppresses liver damage.

  2012cites this paper
• Liver Regeneration and Bioengineering - The Emergence of Whole Organ Scaffolds

  2012cites this paper
• Novel cell therapies for liver disease and type 1 diabetes

  2012cites this paper
• Acute Liver Failure in Intensive Care

  2012cites this paper
• Chapter 97C – Liver transplantation in patients with fulminant hepatitis

  2012cites this paper
• Sistemas de soporte hepático extracorpóreo Extracorporeal liver Support Systems

  2012influential citation
• Advances in Cell Therapy for Liver Disease

  2012cites this paper
• Chapter 72 – Management of liver failure

  2012cites this paper
• Sources of Human Liver Cells and the Challenge of Working with Primary Tissue

  2012cites this paper
• Albumin in Artificial Liver Support Systems

  2012influential citation
• Liver Replacement Therapy

  2012cites this paper
• Acute-on-chronic liver failure: concept, natural history, and prognosis

  2011cites this paper
• Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure.

  2011cites this paper
• Artificial extracorporeal liver support therapy in patients with severe liver failure

  2011cites this paper
• Liver Regeneration: the Role of Bioengineering

  2011cites this paper
• No enhanced expression and infectivity of porcine endogenous retrovirus in primary porcine hepatocytes with chitosan nanofiber scaffold.

  2011cites this paper
• Insufficienza epatica acuta in terapia intensiva

  2011influential citation
• AASLD Position Paper: The Management of Acute Liver Failure: Update 2011

  2011influential citation
• Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes.

  2011cites this paper
• Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland

  2011cites this paper
• Sistemas de soporte hepático extracorpóreo

  2011cites this paper
• The new transplant patient.

  2011cites this paper
• Normal atmospheric oxygen tension and the use of antioxidants improve hepatocyte spheroid viability and function

  2011cites this paper
• Fluidized-bed bioartificial liver assist devices (BLADs) based on microencapsulated primary porcine hepatocytes have risk of porcine endogenous retroviruses transmission

  2010cites this paper
• A new treatment strategy for acute liver failure.

  2010cites this paper
• Bio-artificial liver support system : an evaluation of models used in demonstrating or improving metabolic and clinical efficacy

  2010cites this paper
• The Use and Promise of Stem Cells in Drug Discovery

  2010cites this paper
• Neurological Management of Fulminant Hepatic Failure

  2010cites this paper
• Biology of the adult hepatic progenitor cell: "ghosts in the machine".

  2010cites this paper
• A CRITICAL EVALUATION OF THE MARS TREATMENT IN FINLAND

  2010cites this paper
• A theoretical method to improve and optimize the design of bioartificial livers

  2010cites this paper
• Therapeutic Apheresis in Liver Transplantation

  2010cites this paper
• How to define initial poor graft function after liver transplantation? – a new functional definition by the LiMAx test

  2010cites this paper
• Establishment of a three‐dimensional co‐culture system by porcine hepatocytes and bone marrow mesenchymal stem cells in vitro

  2009cites this paper
• Management of acute liver failure

  2009cites this paper
• In vitro evaluation of a multi-layer radial-flow bioreactor based on galactosylated chitosan nanofiber scaffolds.

  2009cites this paper
• Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver

  2009cites this paper
• Long‐term outcomes of emergency liver transplantation for acute liver failure

  2009cites this paper
• Albumin Dialysis in Liver Failure: Comparison of Molecular Adsorbent Recirculating System and Single Pass Albumin Dialysis—A Retrospective Analysis

  2009cites this paper
• Engineering analysis and development of the spheroid reservoir bioartificial liver

  2009cites this paper
• COMPLICATIONS OF CIRRHOSIS MINISERIES

  2009cites this paper
• Nuevas estrategias terapéuticas en el fallo hepático agudo

  2009cites this paper